Summary

Eligibility
for people ages 18-65 (full criteria)
Location
at UCSD
Dates
study started
completion around
Principal Investigator
by Beatrice A. Golomb, MD, PhD (ucsd)

Description

Summary

This research study is being conducted to see if coenzyme Q10 (a nutritional supplement) might help to prevent and/or alleviate symptoms and health consequences and help to improve quality of life and physical function in residents affected by the February 2023 East Palestine, Ohio train derailment. This is a pilot study that is not powered to achieve benefit but seek to examine effect size and variance to aid in power calculations for a potential future better powered study.

Keywords

Toxicant Induced Chronic Multisymptom Illness and Associated Symptoms and Comorbidities, Mixed toxic chemicals, Chronic multisymptom illness, Train derailment, Ubiquinone, Coenzyme Q10, Ubiquinone 100 mg Oral Soft Gel

Eligibility

Location

  • UC San Diego
    La Jolla California 92093 United States

Lead Scientist at University of California Health

  • Beatrice A. Golomb, MD, PhD (ucsd)
    Professor In Residence, Medicine, Vc-health Sciences-schools. Authored (or co-authored) 103 research publications

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Diego
ID
NCT06962657
Phase
Phase 2
Study Type
Interventional
Participants
Expecting 20 study participants
Last Updated